billion - International Biopharmaceutical Industry

Current Edition

Issue 9, Volume 3

Current Features

Issue 9, Volume 3

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

news

J&J cuts COVID vaccine sales forecasts, citing high supplies and lagging demand

Dive Brief: Johnson & Johnson is lowering its forecast for COVID-19 vaccine sales, announcing Tuesday it will has suspended its guidance of $3 billion to $3.5 ...

25 April 2022 news billion | COVID

Continue Reading →

news

Takeda to Acquire Shire for $62 Billion

Takeda Pharmaceutical Company Limited announced on May 8, 2018 that it has reached agreement on the terms of an offer to acquire Shire plc in a deal valued at $62 bil...

11 May 2018 news 62 | Acquire

Continue Reading →